COVID-19 and Cardiology

Coronavirus disease 2019 (COVID-19), caused by a coronavirus strain known as severe acute respiratory syndrome coronavirus (SARS-CoV-2), has expanded over the world, affecting billions of humans. SARS-CoV-2 has several biological properties with SARS-CoV, the zoonotic virus that caused the severe acute respiratory syndrome epidemic, including the cell entrance pathway, which is triggered by the viral spike protein binding to angiotensin-converting enzyme. COVID-19 appears to be linked to even worse outcomes and an increased mortality risk in patients with well before cardiovascular disease, despite the fact that COVID-19 can cause myocardial injury, arrhythmias, acute coronary syndrome, and venous thromboembolism. Patients with COVID-19 and concomitant cardiovascular disorders are increasing concerned about potential drug–disease interactions.

    Related Conference of COVID-19 and Cardiology

    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    September 19-20, 2024

    7th World Heart and Brain Conference

    London, UK
    September 19-20, 2024

    6th Annual Conference on Vascular Medicine

    London, UK
    October 17-18, 2024

    8th Annual Heart Rhythm Conference

    Barcelona, Spain
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland

    COVID-19 and Cardiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in